Roth Capital Weighs in on Joint's Q4 Earnings (NASDAQ:JYNT)

The Joint Corp. (NASDAQ:JYNT - Free Report) - Equities researchers at Roth Capital dropped their Q4 2024 earnings estimates for Joint in a note issued to investors on Friday, November 8th. Roth Capital analyst G. Kelly now anticipates that the company will post earnings of $0.07 per share for the quarter, down from their previous forecast of $0.15. The consensus estimate for Joint's current full-year earnings is $0.13 per share. Roth Capital also issued estimates for Joint's Q1 2025 earnings at $0.02 EPS, Q2 2025 earnings at $0.05 EPS, Q3 2025 earnings at $0.11 EPS and Q4 2025 earnings at $0.25 EPS.

Several other research firms have also issued reports on JYNT. StockNews.com lowered Joint from a "buy" rating to a "hold" rating in a research note on Thursday. Roth Mkm cut their price objective on Joint from $16.00 to $15.00 and set a "buy" rating for the company in a report on Friday.

Joint Stock Up 8.4 %

NASDAQ:JYNT traded up $0.97 during mid-day trading on Monday, hitting $12.58. 81,764 shares of the stock traded hands, compared to its average volume of 68,252. The business's 50-day moving average price is $11.26 and its 200 day moving average price is $12.97. The company has a market cap of $188.70 million, a PE ratio of -10.66 and a beta of 1.57. Joint has a 12-month low of $8.26 and a 12-month high of $17.82.

Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Joint had a negative net margin of 13.95% and a positive return on equity of 7.89%. The company had revenue of $30.26 million for the quarter, compared to the consensus estimate of $29.65 million.

Hedge Funds Weigh In On Joint

A number of hedge funds and other institutional investors have recently modified their holdings of JYNT. Squarepoint Ops LLC bought a new position in shares of Joint during the 2nd quarter valued at $144,000. Sargent Investment Group LLC bought a new position in shares of Joint during the second quarter valued at about $150,000. XTX Topco Ltd purchased a new position in shares of Joint in the second quarter worth about $174,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Joint by 5.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company's stock worth $229,000 after buying an additional 837 shares during the period. Finally, Avondale Wealth Management lifted its stake in shares of Joint by 15.8% in the 2nd quarter. Avondale Wealth Management now owns 22,000 shares of the company's stock valued at $309,000 after acquiring an additional 3,000 shares during the last quarter. 76.88% of the stock is currently owned by hedge funds and other institutional investors.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.